We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 2,727 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/8/2018 12:43 | Certainly think there is a company or two keeping a very close eye on SBTX. In 6 months the share price is likely to be 2 or 3 times the current share price assuming the human skin trials are a success. However, we have anecdotal evidence showing that the team at SBTX are currently using the cream. We also know it has been tested on human skin in the lab. I believe the likelihood is that the human skin trials will be a success and that a deal will follow on fairly quickly. Just my personal view. | rafboy | |
02/8/2018 12:10 | Up we go again - can't help feeling there may be partner announcements before the trial is completed | deeppockets | |
01/8/2018 14:25 | Agreed, then the Excema and other application further down the line! | deeppockets | |
01/8/2018 14:20 | Deep Successful trials will be followed very closely by a commercial agreement IMHO and that will likely be a global player. What will that do to the market cap? Shrewdie | shrewdmole | |
01/8/2018 14:06 | Cath (CEO) also said the team use the cream already! | deeppockets | |
01/8/2018 14:02 | Trimmed a few up here, looking for a period of consolidation or will add if it sets up after any retrace. | matt123d | |
01/8/2018 09:50 | Wreck 100p is very achievable on positive human trials. Worth noting for newcomers they've already tested on human skin in the lab. Scale up production testing has been done and dosage tests. Shrewdie | shrewdmole | |
01/8/2018 08:05 | I get the feeling OPTI investors are slicing to drop into their spin-off company, SBTX. As OPTI heads up, SBTX does the same. Could be seeing 100p here. WT | wrecktangle | |
31/7/2018 19:59 | I like OPTI but I feel skin has always been the golden egg. | jamjason | |
31/7/2018 19:28 | News imminent? maybe; £50K. after hours purchase. Meaty. | owenmo | |
31/7/2018 16:08 | Someone put the brakes on I'm not in a position to add at the moment! | smarner | |
31/7/2018 15:46 | Someone's bidding these up to obtain stock. | matt123d | |
31/7/2018 15:44 | Jeez - news imminent? Trial not due to start for a few weeks - partnership developments? | deeppockets | |
31/7/2018 15:41 | Heading for 30p now! | matt123d | |
31/7/2018 15:39 | Blimey, moving fast now. | rafboy | |
31/7/2018 13:27 | raft boy, don’t think you will have any problem’s doubling your investment if they get the product to do as they want, I was in OPTI from the IPO bailed out 2 weeks ago took my profits and re-invested in SBTX. This is going the same way as the big brother, the next biggie is the sugar when that is spun off I intend to pile in, the potential is mind boggling. GLA. | warren1982 | |
31/7/2018 13:03 | Back to 21.5 just now | lizslave | |
31/7/2018 11:44 | I am hoping for double from here by year end at the very least. | rafboy | |
31/7/2018 11:38 | Hopefully it will follow in its daddys footsteps 😉 | scotty1 | |
31/7/2018 11:12 | 4826 triples my holding, my biggest ever and more than i have in Opti. I was late to that party. Ok it took a while to get started. Happy days. | slartybartfaster | |
30/7/2018 10:45 | Was that to buy OPTI on the short drop? | rafboy | |
30/7/2018 10:22 | Someone's been dumping a load of stock this morning, expecting a retrace back to circa 17p. | rathean | |
28/7/2018 19:10 | CGT for OPTI on disposal profit of SBTX shares? | semper vigilans |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions